ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

1,2,4,7,9-ペンタクロロジベンゾ-p-ジオキシン

1,2,4,7,9-Pentachlorodibenzo-P-dioxin

HCID 54847
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
82291-37-0
標準SMILES
Clc1cc(Cl)c2c(c1)Oc1c(Cl)cc(Cl)c(Cl)c1O2
InChIKey
QLBBXWPVEFJZEC-UHFFFAOYSA-N
分子式
C12H3Cl5O2
平均分子量
356.4 g/mol
単同位体質量
353.857568

概要

1,2,4,7,9-Pentachlorodibenzo-p-dioxin is one of 75 chlorinated dibenzo-p-dioxin (CDD) congeners. CDDs are a class of manufactured chemicals that consist of dioxin skeletel structures with chlorine substituents. They are also persistent organic pollutants (POPs), thus their production is regulated in most areas. Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

名称と識別子

優先名称
1,2,4,7,9-Pentachlorodibenzo-P-dioxin
IUPAC
1,2,4,7,9-pentachlorodibenzo-p-dioxin
現地名
1,2,4,7,9-ペンタクロロジベンゾ-p-ジオキシン
英語名
1,2,4,7,9-Pentachlorodibenzo-p-dioxin
分子式
C12H3Cl5O2
分子量
356.42

名称と別名

1,2,4,7,9-Pentachlorodibenzo-p-dioxin82291-37-0UNII-CH9NOD25WTCH9NOD25WTPCDD 61Dibenzo(b,e)(1,4)dioxin, 1,2,4,7,9-pentachloro-1,2,4,7,9-pentachloro dibenzo-p-dioxin1,2,4,7,9-PENTACHLOROOXANTHRENEDibenzo-p-dioxin, 1,2,4,7,9-pentachloroDTXSID80741081,2,4,7,9-PECDD1,2,4,7,9-PENTACHLORODIBENZODIOXIN
名称をさらに表示
1,2,4,7,9-ペンタクロロジベンゾ[b,e][1,4]ジオキシン1,2,4,7,9-ペンタクロロジベンゾ[1,4]ジオキシン1,3,4,6,8-ペンタクロロジベンゾ-p-ジオキシン1,2,4,7,9-ペンタクロロジベンゾ-p-ジオキシン1,2,4,7,9-PCDD1,2,4,7,9-ペンタクロロオキサントレン1,2,4,7,9-PCDD1,3,4,6,8-Pentachlorodibenzo-p-dioxin1,2,4,7,9-Pentachlorodibenzo[1,4]dioxin1,2,4,7,9-Pentachlorodibenzo[b,e][1,4]dioxin
RefChem:71491DTXCID8048286QLBBXWPVEFJZEC-UHFFFAOYSA-NNS00124699Q27275457

データベース識別子

物性

構造計算による物性

XLogP
7.1
極性表面積
18.5 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
0
重原子数
19
形式電荷
0
複雑度
344

物理化学的性質

Henry's Law Constant
1.2 · 1.2×100 mol/(m3Pa) at 25℃, Wang and Wong (2002)
EPAの化学物質情報
1 · 1,2,4,7,9-Pentachlorodibenzo-p-dioxin (82291-37-0)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全と保護具

Minimum Risk LevelAcute Oral: 0.0002 ug/kg/day (L134) Intermediate Oral: 0.00002 ug/kg/day (L134) Chronic Oral: 0.000001 ug/kg/day (L134)

毒性情報

TreatmentTreatment of CDD exposure may include washing the area of contact, GI decontamination, administering an IV, or forced alkaline diuresis. (L346)
Health Effects · 1 件

Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathology, thyroid disorders, endometriosis, and diabetes. (L177, L178)

Exposure RoutesOral (L177) ; inhalation(L177) ; dermal (L177)
Toxicity Summary · 1 件

CDDs cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. (L177)

Signs and SymptomsIn addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (L177)

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the faeces, though smaller amounts are excreted in the urine and via lactation. (L177)

用途と製造

Uses · 1 件

Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

サプライヤー2 社

上海稳同科技有限公司02151600108 13062666369 · [email protected]
青岛腾龙微波科技有限公司0532-83818797 17669478191 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
CAS
82291-37-0
PubChem CID
54847
DTXSID
DTXSID8074108
UNII
CH9NOD25WT
Nikkaji
J372.962A
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)